Register | Login | Search | Contact Us | Terms of Use
Product Information About Shaklee Latest News Shaklee Science Tools and Resources

Please install Flash and turn on Javascript.

Tools and Resources

Ephedra/Ma-Huang
(Ephedra sinica)


 General Info  

Active Forms


Absorption


Dietary Sources


 Dosage Info
Dosage Range
Dosages recommended by manufacturers and those typically used in clinical studies range from 8-25mg ephedra alkaloids per dose, no more than 4 times a day.

Tea: Made with 1 to 4 gm, 3 times daily.(1)

Tincture (1:1): medium single dose 5 gm.(1)

Extract: 1 to 3 ml, 3 times daily.(1)

Tincture (1:4): 6 to 8 ml, 3 times daily.(1)

Most Common Dosage
25mg ephedra alkaloids, 3 to 4 times per day.

American Herbal Products Association (AHPA) recommended dosage: do not exceed 25mg, 4 times per day.

Tea: Made with 1 gm, 3 times daily.

Tincture (1:1): medium single dose 5 gm.

Extract: 1 ml, 3 times daily.

Tincture (1:4): 6 ml, 3 times daily.

Dosage Forms

Adult RDI


Adult ODA


 
 Overview
Interactions
Drug/Herb Interactions
Central nervous system stimulants
Decongestants
MAO inhibitors
Oral and inhaled anti-asthmatic medications

Warning:
Not intended for use by anyone under the age of 18. Do not use this product if you are pregnant or nursing. Consult a health care professional before using this product if you have heart disease, thyroid disease, diabetes, high blood pressure, psychiatric condition, difficulty in urinating, prostate enlargement, or seizure disorder, if you are using a monoamine oxidase inhibitor (MAOI) or any other prescription drug, or you are using an over-the-counter drug containing ephedrine, pseudoephedrine or phenylpropanolamine (ingredients found in certain allergy, asthma, cold/cough and weight control products).

Exceeding recommended serving will not improve results and may cause serious adverse health effects.

Discontinue use and call a health care professional immediately if you experience rapid heartbeat, dizziness, severe headache, shortness of breath, or similar symptoms.(2)

Ephedra has been used traditionally for thousands of years in China. Its uses include acute nephritis, asthma and other lung problems, colds and flu, fever, chills, lack of perspiration, headache, nasal congestion, wheezing, and cough among others.(3, 4) Recently, ephedra supplements have been under scrutiny due in part to the irresponsible use of ephedra products by some individuals and also due to the inappropriate advertising of ephedra products by some manufacturers. In fact, ephedra has been reviewed and in some cases regulated by several State Boards of Pharmacy for appropriate control and dosage of the supplement.(5) A recent laboratory animal study of one of the “herbal ecstasy” products reported that this ephedra product may actually produce an amphetamine-like stimulus.(6)

The safe dosage of ephedra and ephedra-containing products has been heavily debated. The quantity of ephedra alkaloids in dietary supplements, as reported on package labels, is typically around 8 to 25mg per serving, and the usual dosage frequency is two to three times per day and not more than 4 times per day. However, some products may contain larger or smaller amounts of ephedra alkaloids than are listed on the product label. In one study, 11 of 20 supplements tested either failed to list the alkaloid content on the label or had more than a 20 percent difference (either lower or higher) between the amount listed on the label and the actual amount.(7) It is also important to realize that usually the ephedra weight loss products contain other stimulating ingredients, such as caffeine, guarana and bitter orange (citrus aurantium) which contains synephrine.

There have not been many clinical studies conducted on this traditionally used herb. A recent review of 140 reports of adverse events related to the use of dietary supplements containing ephedra alkaloids was conducted. These reports were submitted to the FDA between June 1, 1997, and March 31, 1999. Thirty-one percent of cases were considered to be definitely or probably related to the use of supplements containing ephedra alkaloids, and 31 percent were deemed to be possibly related. Among the adverse events that were deemed definitely, probably, or possibly related to the use of supplements containing ephedra alkaloids, 47 percent involved cardiovascular symptoms and 18 percent involved the central nervous system. Hypertension was the single most frequent adverse effect (17 reports), followed by palpitations, tachycardia, or both (13); stroke (10); and seizures (7). Ten events resulted in death, and 13 events produced permanent disability, representing 26 percent of the definite, probable, and possible cases. It is worth noting that several of the reports reviewed in the study involved individuals with pre-existing medical condi

 Toxicities & Precautions
General
In recommended dosages, ephedra has a long history of being safe. Exceeding the recommended dose will not improve results and may cause serious adverse health effects.(8)

Health Conditions
Use with extreme caution in individuals with renal impairment, glaucoma, hypertension, cardiovascular disease, thyroid disease, diabetes, psychiatric disorders, seizure disorders, difficulty urinating or enlarged prostate.(9, 10, 11, 12, 13, 14)

Side Effects
If abused, taken in high dosages, or taken in pre-existing cardiovascular diseases, ephedra may contribute to adverse events. There are several deaths reported from overdosage of ephedra.(15, 16)

Symptoms of overdosage include heart palpitations, extreme nervousness, sweating, enlarged pupils, severe headache, dizziness, dyspnea, elevated body temperature, and ultimately death.(17)

There has been a report of hepatitis associated with the use of ephedra.(18)

Pregnancy/Breast-Feeding
Use is contraindicated in pregnancy and lactation.

Age Limitations
This dietary supplement should not be used by anyone under 18 years of age.

 Symptoms & Causes of Deficiency
 Footnotes
1 PDR for Herbal Medicines, 2nd ed. Montvale, NJ: Medical Economics Company; 2000:489.
2 American Herbal Products Association. Current Trade Recommendations, AHPA Code of Ethics and Business Conduct. Silver Spring, MD: American Herbal Products Association; Mar1994.
3 Kalix P. The pharmacology of psychoactive alkaloids from ephedra and catha. J Ethnopharmacol. Apr1991;32(1-3):201-8.
View Abstract
4 Chan EL, et al. History of medicine and nephrology in Asia. Am J Nephrol. 1994;14(4-6):295-301.
View Abstract
5 Adverse Events Associated with Ephedrine-Containing Products--Texas, December 1993-September 1995. Morbidity Mortality Weekly Report MMWR. Aug1996;45(32):689-92.
View Abstract
6 Glennon RA, et al. (+)Amphetamine-stimulus generalization to an herbal ephedrine product. Pharmacol Biochem Behav. Apr2000;65(4):655-8.
View Abstract
7 Gurley BJ, Gardner SF, Hubbard MA. Content versus label claims in ephedra-containing dietary supplements. Am J Health Syst Pharm. May2000;57(10):963-9.
View Abstract
8 Haller CA, Benowitz NL. Adverse Cardiovascular and Central Nervous System Events Associated with Dietary Supplements Containing Ephedra Alkaloids. N Engl J Med. Dec2000;343(25):1833-8.
View Abstract
9 LaValle JB, et al. Natural Therapeutics Pocket Guide. Hudson, OH: LexiComp, Inc; 2000:429-430.
10 Powell T, et al. Ma-huang strikes again: ephedrine nephrolithiasis. Am J Kidney Dis. Jul1998;32(1):153-9.
View Abstract
11 Zaacks SM, et al. Hypersensitivity myocarditis associated with ephedra use. J Toxicol Clin Toxicol. 1999;37(4):485-9.
View Abstract
12 Jacobs KM, et al. Psychiatric complications of Ma-huang. Psychosomatics. Jan2000;41(1):58-62.
13 Capwell RR. Ephedrine-induced mania from an herbal diet supplement. Am J Psychiatry. Apr1995;152(4):647.
14 Harada M, et al. Contribution of alkaloid fraction to pressor and hyperglycemic effect of crude Ephedra extract in dogs. J Pharmacobiodyn. Sep1981;4(9):691-9.
View Abstract
15 Thoeharides TC. Sudden death of a healthy college student related to ephedrine toxicity from a ma huang-containing drink. J Clin Psychopharmacol. Oct1997;17(5):437-9.
16 Gurley BJ, et al. Ephedrine pharmacokinetics after the ingestion of nutritional supplements containing Ephedra sinica (ma huang). Ther Drug Monit. Aug1998;20(4):439-45.
View Abstract
17 PDR for Herbal Medicines, 2nd ed. Montvale, NJ: Medical Economics Company; 2000:489.
18 Nadir A, et al. Acute hepatitis associated with the use of a Chinese herbal product, ma-huang. Am J Gastroenterol. Jul1996;91(7):1436-8.
View Abstract
 
Register | Login | Search | Contact Us | Terms of Use | FAQ

Shaklee Health Network
© 1998-2006 Shaklee Corporation